TENAX THERAPEUTICS, INC. Additional Paid in Capital, Common Stock
TENAX THERAPEUTICS, INC. (TENX) had Additional Paid in Capital, Common Stock of $272.95 million as of 2021-06-30, per its 10-Q filed 2021-08-16.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:AdditionalPaidInCapitalCommonStock · last filed 2021-08-16
- 2021-06-30: Additional Paid in Capital, Common Stock $272.95M.
- 2021-03-31: Additional Paid in Capital, Common Stock $272.86M.
- 2020-12-31: Additional Paid in Capital, Common Stock $250.64M.
- 2020-09-30: Additional Paid in Capital, Common Stock $250.59M.
| Period end | Additional Paid in Capital, Common Stock |
|---|---|
| 2021-06-30 | $272.95M 10-Q · filed 2021-08-16 |
| 2021-03-31 | $272.86M 10-Q · filed 2021-05-17 |
| 2020-12-31 | $250.64M 10-Q · filed 2021-08-16 |
| 2020-09-30 | $250.59M 10-Q · filed 2020-11-16 |
| 2020-06-30 | $244.00M 10-Q · filed 2020-08-14 |
| 2020-03-31 | $242.24M 10-Q · filed 2020-05-15 |
| 2019-12-31 | $239.94M 10-K/A · filed 2021-04-16 |
| 2019-09-30 | $239.91M 10-Q · filed 2019-11-14 |
| 2019-06-30 | $239.77M 10-Q · filed 2019-08-14 |
| 2019-03-31 | $239.73M 10-Q · filed 2019-05-15 |
| 2018-12-31 | $239.57M 10-K · filed 2020-03-30 |
| 2018-09-30 | $223.03M 10-Q · filed 2018-11-14 |
| 2018-06-30 | $222.80M 10-Q · filed 2018-08-14 |
| 2018-03-31 | $222.71M 10-Q · filed 2018-05-15 |
| 2017-12-31 | $222.40M 10-K · filed 2019-04-01 |
| 2017-09-30 | $222.32M 10-Q · filed 2017-11-09 |
| 2017-06-30 | $222.19M 10-Q · filed 2017-08-09 |
| 2017-03-31 | $222.06M 10-Q · filed 2017-05-10 |
| 2016-12-31 | $221.82M 10-K · filed 2018-04-02 |
| 2016-09-30 | $221.65M 10-Q · filed 2016-11-09 |
| 2016-06-30 | $221.54M 10-Q · filed 2016-08-09 |
| 2016-03-31 | $221.42M 10-Q · filed 2016-05-10 |
| 2015-12-31 | $221.29M 10-K · filed 2017-03-16 |
| 2015-10-31 | $221.17M 10-Q · filed 2015-12-10 |
| 2015-07-31 | $221.11M 10-Q · filed 2015-09-09 |
| 2015-04-30 | $221.07M 10-KT · filed 2016-03-14 |
| 2015-01-31 | $220.99M 10-Q · filed 2015-03-17 |
| 2014-10-31 | $220.44M 10-Q · filed 2014-12-15 |
| 2014-07-31 | $220.36M 10-Q · filed 2014-09-15 |
| 2014-04-30 | $219.47M 10-KT · filed 2016-03-14 |
| 2014-01-31 | $156.47M 10-Q · filed 2014-03-17 |
| 2013-10-31 | $125.67M 10-Q · filed 2013-12-17 |
| 2013-07-31 | $120.42M 10-Q · filed 2013-09-17 |
| 2013-04-30 | $115.27M 10-K · filed 2014-07-29 |
| 2013-01-31 | $113.58M 10-Q · filed 2013-03-18 |
| 2012-10-31 | $112.71M 10-Q · filed 2012-12-14 |
| 2012-07-31 | $110.57M 10-Q · filed 2012-09-19 |
| 2012-04-30 | $107.28M 10-K · filed 2013-06-26 |
| 2012-01-31 | $104.14M 10-Q · filed 2012-03-15 |
| 2011-10-31 | $93.99M 10-Q · filed 2011-12-15 |
| 2011-07-31 | $93.16M 10-Q · filed 2011-09-19 |
| 2011-04-30 | $88.19M 10-K · filed 2012-07-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |